BIOLOGICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING DENDRITIC CELLS, NATURAL KILLER CELLS AND CYTOTOXIC T CELLS

WIPO Patent Application WO/2023/038492

A1

The present invention relates to a pharmaceutical composition for preventing or treating cancer and, more specifically, the present invention comprises dendritic cells, natural killer cells and cytotoxic T cells, and thus exhibits anticancer effects that are better than those of when each type of cell is used alone. In addition, if a pharmaceutical composition of the present invention comprises co-cultured dendritic cells, natural killer cells and cytotoxic T cells, anticancer effects that are better than those of when each type of cell is used alone or used in a simple combination are exhibited.

LEE JONG KYUN (KR)
LEE HA NA (KR)
PARK JIN JU (KR)
KIM YEA WON (KR)
LEE HYUN JI (KR)
LEE NA HYE (KR)
CHE DENIS NCHANG (KR)
HAM WON KOOK (KR)
LEE HYO JUNG (KR)

PCT/KR2022/013616

March 16, 2023

September 13, 2022

Click for automatic bibliography generation  

LEE JONG KYUN (KR)

A61K35/17; A61P35/00; C12N5/0783; C12N5/0784

WO2012175598A1

2012-12-27

JPH11290068A	1999-10-26
KR20190129046A	2019-11-19
CN106047810A	2016-10-26

WONG, JEFFREY L.; MAILLIARD, ROBBIE B.; MOSCHOS, STERGIOS J.; EDINGTON, HOWARD; LOTZE, MICHAEL T.; KIRKWOOD, JOHN M.; KALINSKI, PA: "Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells", JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 34, no. 3, 1 April 2011 (2011-04-01), US , pages 270 - 278, XP009544378, ISSN: 1524-9557, DOI: 10.1097/CJI.0b013e31820b370b

LEECHAE INTELLECTUAL PROPERTY (KR)

View/Download PDF      PDF Help

Previous Patent: OPERATION METHOD RELATED TO PATH SWITCHING IN SIDELINK IN WIRELESS COMMUNICATION SYSTEM

Next Patent: COMPOUND, COATING COMPOSITION INCLUDING SAME, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACT...